Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prucalopride in Chronic Intestinal Pseudo-Obstruction (CIP)
NCT00793247Phase 2Completed
- Sponsor
- Movetis
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of prucalopride in chronic intestinal pseudo-obstruction (CIPO) (4 arms), sponsored by Movetis. Status: completed.
02
Drugs
prucalopride
03
Conditions
chronic intestinal pseudo-obstruction (CIPO)
Beyond the preview
Go deeper on NCT00793247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00793247.